We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Quarterly Royalty Payments Sample Clauses

Quarterly Royalty PaymentsBeginning with the first royalty payment due Tessera from Licensee after the First Addendum Effective Date, royalties shall be calculated and paid in full in quarter annual payment periods ending March 31, June 30, September 30 and December 31 of each year. Beginning with the first such royalty payment, Licensee shall deliver a written report (as shown in Addendum Attachment A) within twenty (20) days from the last day of each quarter annual payment period describing the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period (by facsimile, with an original by mail courier). Tessera shall then invoice Licensee (by facsimile, with an original by mail courier) for the royalties due Tessera as set forth in each such Licensee written royalty report. Licensee shall then have thirty (30) days from first receipt of Tessera’s invoice to pay the royalties due under Tessera’s invoice. All payments under this Paragraph shall be made in US Dollars by wire transfer to Union Bank of California, 00 Xxxxxxx Xxxx., Xxx Xxxx, XX 00000, Account Name: Tessera, Account No.: 6450148359, Routing No. 000000000, International Swift Code: XXXXXX00, or such other bank or account as Tessera may from time to time designate in writing. The payments of royalties shall be considered to be made as of the day on which such payments are received in Tessera’s designated bank account.
Quarterly Royalty PaymentsSeparate and apart from IP Purchase Payment and Warrant under Section 1 and the Minimum Annual Royalty Payments under Section 2.1, and subject to Section 2.3 below, Buyer shall provide royalty payments to Seller, payable on a quarterly basis ("Quarterly Royalty Payments"), based on Net Sales by Buyer (or its affiliates, licensees, or subsidiaries) of any device or system developed, in whole or in part, by Xx. Xxxx Xxxxxx under that certain Clinical Advisor and Development Agreement between NuVasive and Xx. Xxxx Xxxxxx dated October 10, 2002, or otherwise enabled by the assignment of the Intellectual Property Rights under Section 1 ("Assigned Technology"), but only to the extent the Quarterly Royalty Payments due Seller during each twelve (12) month period following the Effective Date exceed the Minimum Annual Royalty Payment, according to the following terms: (a) of Net Sales in the United States; (b) of Net Sales on direct international sales in countries where patent protection is obtained for the Assigned Technology; (c) of Net Sales on discounted indirect international dealer sales in countries where patent protection is obtained for the Assigned Technology; and (d) of Net Sales on international sales in countries where patent protection is not obtained for the Assigned Technology. For purposes of this Agreement, "Net Sales" shall be defined as the actual invoiced price billed to the hospital and/or other professional end users of the Assigned Technology, net of: sales commissions, returns, transportation charges and any applicable taxes.
Quarterly Royalty Payments. Any payment due to Seller under Section 2.2 shall be made by Buyer within thirty (30) days after the end of each calendar quarter and shall be accompanied by an accurate statement of Net Sales of the Assigned Technology and any reduction in Quarterly Royalty Payments based on Section 2.3. The Quarterly Royalty Payments under Section 2.2 shall remain payable and due Seller for the period during which all patent claims covering Assigned Technology resulting from Intellectual Property Rights, or any later acquired patent rights to Assigned Technology developed under that certain Clinical Advisor and Development Agreement between NuVasive and Xx. Xxxx Xxxxxx dated October 10, 2002, remain valid and enforceable.
Quarterly Royalty Payments. All Earned Royalties due by either party to the other party hereunder shall be payable on a calendar quarterly basis. Within sixty (60) days after the end of each Calendar Quarter during the term of this Agreement, each party owing an Earned Royalty under Paragraphs 3.2 or 3.3 shall pay the Earned Royalty owed to the other party through the end of the
Quarterly Royalty Payments. With each such report submitted, Licensee shall pay to USM the royalties due under this Agreement. If no royalties shall be due, Licensee shall so report.
Quarterly Royalty Payments. Beginning on the Effective Date of this Agreement, royalties shall be calculated and paid in full in quarter annual payment periods ending March 31, June 30, September 30 and December 31 of each year. Beginning with the first such royalty payment, Licensee shall deliver a written report (as shown in Attachment B) describing the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period. All payments under this Paragraph shall be made in US Dollars by wire transfer to Union Bank of California, 00 Xxxxxxx Xxxx., Xxx Xxxx, XX 00000, Account Name: Tessera, Account No.: 6450148359, Routing No. 000000000, International Swift Code: XXXXXX00, or such other bank or account as Tessera may from time to time designate in writing. The payments of royalties and submission such reports from Licensee to Tessera under this *Confidential Treatment Requested. Paragraph shall be made within thirty (30) days from the end of each quarter annual payment period and shall be considered to be made as of the day on which such payments are received in Tessera's designated bank account.
Quarterly Royalty Payments. Beginning on the Effective Date of this Agreement, royalties shall be calculated and paid in full in quarter annual payment periods ending March 31, June 30, September 30 and December 31 of each year. Beginning with the first such royalty payment, Licensee shall deliver a written report (as shown in Attachment B) describing the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period. All payments under this Paragraph shall be made in US Dollars by wire transfer to Union Bank of California, 99 Axxxxxx Xxxx., Xxx Xxxx, XX 00000, Xxcount Name: Tessera, Account No.: 6450148359, Routing No. 122000000, Xxternational Swift Code: UBLAXX00, xx such other bank or account as Tessera may from time to time designate in writing. The payments of royalties and submission such reports from Licensee to Tessera under this * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. TESSERA CONFIDENTIAL Paragraph shall be made within thirty (30) days from the end of each quarter annual payment period and shall be considered to be made as of the day on which such payments are received in Tessera's designated bank account.
Quarterly Royalty Payments. Beginning on the Effective Date of this Agreement, royalties shall be calculated and paid in full in quarter annual payment periods ending March 31, June 30, September 30 and December 31 of each year. Beginning with the first such royalty calculation and payment, Licensee shall deliver a written report (as shown in Attachment B) describing the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period. All payments under this Paragraph shall be made in US Dollars by wire transfer to Union Bank of California, 99 Axxxxxx Xxxx., Xxx Xxxx, XX 00000, Xxcount Name: Tessera, Account No.: 6450148359, Routing No. 122000000, Xxternational Swift Code: UBLAXX00, xx such other bank or account as Tessera may from time to time designate in writing. Licensee will further submit with each such calculation report, an accounting of the total quantity of TCCs manufactured by Licensee as compared to the total quantity of TCCs manufactured for Licensee by a separate Tessera TCC assembly licensee. The payments of royalties and submission of royalty reports from Licensee to Tessera under this Paragraph shall be made within sixty (60) days from the end of each reporting calendar quarter and shall be considered to be made as of the day on which such payments are received in Tessera's designated bank account.
Quarterly Royalty PaymentsBeginning with the quarter annual period starting on January 1, 2005, royalties shall be calculated and paid in full in quarter annual payment periods ending March 31, June 30, September 30 and December 31 of each year. Beginning with the first such royalty payment and until the annual cumulative total of Licensee’s royalty payments and reports to Tessera equal or exceed the Annual Royalty Target, Licensee shall deliver a written report (as shown in Attachment B) within thirty (30) days from the last day of each quarter annual payment period describing (i) the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period (by facsimile, with an original by mail courier), (ii) the purchases by Licensee of TCC packages from companies that are not Licensee Affiliate companies, and (iii) any Royalty Adjustments. After Licensee’s royalty payments to Tessera equal the Annual Royalty Target, Licensee shall deliver a written report (as shown in Attachment C) within thirty (30) days from the last day of each quarter annual payment period describing (i) the basis upon and containing the information sufficient to determine the royalties due Tessera for the applicable payment period (by facsimile, with an original by mail courier), (ii) the purchases by Licensee of TCC packages from companies that are not Licensee Affiliate companies, and (iii) any Royalty Adjustments. Tessera shall then invoice Licensee (by facsimile, with an original by mail courier) for any royalties due Tessera as set forth in each such Licensee written royalty report. Licensee shall then have thirty (30) days from first receipt of Tessera’s invoice to pay the royalties due under Tessera’s invoice. All payments under this Paragraph shall be made in US Dollars by wire transfer to Union Bank of California, 00 Xxxxxxx Xxxx., Xxx Xxxx, XX 00000, Account Name: Tessera, Account No.: 6450148359, Routing No. 000000000, International Swift Code: XXXXXX00, or such other bank or account as Tessera may from time to time designate in writing. The payments of royalties shall be considered to be made as of the day on which such payments are received in Tessera’s designated bank account.
Quarterly Royalty PaymentsSeparate and apart from IP Purchase Payment of Section 1 and the Milestone Payment of Section 2.1, and subject to Section 2.3 below, Buyer shall provide royalty payments to Seller, payable on a quarterly basis (“Quarterly Royalty Payments”), based on Net Sales by Buyer (or its affiliates, licensees, or subsidiaries) of any device or system developed, in whole or in part, by Xx. Xxxx Xxxxxx under that certain Clinical Advisor and Development Agreement between NuVasive and Xx. Xxxx Xxxxxx dated August 12, 2005 (the “Advisor Agreement”), or otherwise resulting from or directly enabled by the assignment of the Intellectual Property Rights under Section 1 (“Assigned Technology”), according to the following terms: (a) For sales in the United States: (i) *** % of Net Sales of *** Products manufactured from any synthetic material (including but not limited to poly-ether-ether-keytone) (“ *** Products”); and (ii) *** % for *** Products manufactured from bone allograft (“ *** Products”); (b) For direct international sales in countries where patent protection is obtained for the Intellectual Property Rights: (i) *** % of Net Sales of *** Products; and (ii) *** % of Net Sales of *** Products; (c) For discounted indirect international sales in counties where patent protection is obtained for the Intellectual Property Rights: (i) *** % of Net Sales of *** Products; and (ii) *** % of *** Products; and (d) For international sales in countries where no patent protection is obtained for the Intellectual Property Rights: (i) *** % of Net Sales of *** Products; and (ii) *** % of Net Sales of *** Products.